News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List
Vinod Balachandran/mskcc.org
May 8, 2025, 16:44

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

Vinod Balachandran, Chief of the Olayan Center for Cancer Vaccines at Memorial Sloan Kettering Cancer Center (MSK), 2024 Yvonne Award recipient for “Breakthrough Research”, shared a post on LinkedIn:

“Grateful and humbled to make the 2025 TIME100HEALTH list with such inspiring global health leaders.
This honor reflects my team – they are unrelenting in their efforts to advance new treatments for pancreatic cancer!”

Vinod Balachandran was recognized with the 2024 Yvonne Award in the Breakthrough Research category, presented by OncoDaily and the Youredjian Family Charitable Foundation during ASCO 2024.

The Yvonne award, symbolizing the strength and longevity of the yew tree, honors outstanding contributions to oncology.

Vinod Balachandran, OncoDaily Party and Yvonne Award 2024 - May 31, 2024. Chicago, USA

cancer Headlines OncoDaily Oncology Vinod Balachandran Yvonne Award
Special Coverage
Blog
Jul 2, 2025, 17:48
Riya Patel: First Day as GI Medical Oncologist at the Zuckerberg Cancer Center
Blog
Jul 2, 2025, 17:38
Sergio Cifuentes: Important Information for Colleagues from LATAM Interested in GI Oncology
Blog
Jul 2, 2025, 17:27
Sarah Sammons: Dana-Farber’s Breast Oncology Center and Dr. Waks Debates Standard of Care in Stage II/III Her2+ Breast Cancer
Blog
Jul 2, 2025, 17:12
Benjamin Schrank: I’ve Joined MD Anderson Cancer Center as an Assistant Professor and Physician-Scientist in Radiation Oncology
Blog
Jul 2, 2025, 16:59
Salvador Jaime-Casas: The promise and pitfalls of predictive biomarkers in mUC
Blog
Jul 2, 2025, 16:42
Katsuaki Maehara: TTF-1 is a New Marker to Identify Patients Best Suited for Lung Cancer KRAS Inhibitors 
Insight
Jul 2, 2025, 16:16
Paolo Tarantino: Randomized phase 2 trial of neoadjuvant ARX788 + Pyrotinib vs TCHP for HER2+ BC
Blog
Jul 2, 2025, 16:01
Naveen Pemmaraju: A Very Happy July 1 to All Starting Their Medical Journey
Blog
Jul 2, 2025, 15:53
Paolo Muto: My Last Day of Work at Pascale Full of Affection And Gratitude
Blog
Jul 2, 2025, 15:42
Zainab Sani D.: Where is The Hype for National Cancer Survivors Month? 
Blog
Jul 2, 2025, 15:32
Cancer Isn’t Just Genetic, It’s Contagious - CancerWorld
Blog
Jul 2, 2025, 15:25
Harish Nagaraj: Case Highlight - Metastatic Carcinoma of Unknown Primary